Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04931251 · ClinicalTrials.gov registry record · NA
Addressing Cancer-Related Financial Toxicity in Rural Oncology Care Settings
A NA study of Neoplasms and Carcinoma, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 258
- Enrollment target
- 8
- Study locations
NCT04931251: Completed NA study of Neoplasms and Carcinoma, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT04931251 is a NA study of Neoplasms and Carcinoma that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 258 participants, below the 1,620-participant average among 158 other Neoplasms trials with a reported enrollment target (84% lower). The trial reports 8 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04931251, a NA study of Neoplasms and Carcinoma, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 258 participants
- Enrollment target
- 8
- Study locations
Study Summary
The financial burden, or financial toxicity (FT), of cancer is a consequential and growing problem, particularly for rural patients. It is important to improve our understanding of how financial navigation (FN) can reduce the material, psychological, and behavioral burden of costs associated with cancer care in both rural and non-rural community settings. The purpose of this study is to conduct a financial navigation program in 5 rural and 4 non-rural oncology practices in North Carolina and evaluate the effects of financial navigation on patient outcomes, including financial toxicity and health-related quality of life.
Primary Outcome
To evaluate the change from baseline to follow-up in scores from the Comprehensive Score for Financial Toxicity (COST) measure after participation in the financial navigation program among 780 rural and non-rural NC cancer patients with high baseline financial distress.
Interventions
- BEHAVIORAL Financial Navigation
Study Locations (8)
North Carolina
- NC Basnight Cancer Hospital - Chapel Hill
- Novant Health - Charlotte
- Vidant Medical Center, Cancer Center - Greenville
- Pardee UNC Health Care, Pardee Cancer Center - Hendersonville
- UNC Lenoir Cancer Care Services - Kinston
- Carteret Health Care Cancer Center - Morehead City
- The Outer Banks Hospital - Nags Head
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2021-11-11 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
What the finished NCT04931251 record still lists
NCT04931251 is an interventional study that assigns participants to a tested intervention. The registered 258 participants enrollment target is mid-sized for trials with a published cap, below the 1,620-participant average among 158 other Neoplasms trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Financial Navigation is the first listed.
NCT04931251 lists 8 locations in 1 state (North Carolina).
Frequently Asked Questions
What is clinical trial NCT04931251 about?
NCT04931251 is a clinical study titled "Addressing Cancer-Related Financial Toxicity in Rural Oncology Care Settings". The financial burden, or financial toxicity (FT), of cancer is a consequential and growing problem, particularly for rural patients. It is important to improve our understanding of how financial navigation (FN) can reduce the material, psychological, and behavioral burden of costs associated with ca...
What is the current status of trial NCT04931251?
This trial is currently completed. It is a NA study. The enrollment target is 258 participants. The study started on 2021-11-11. Estimated completion is 2025-07-31.
What conditions does trial NCT04931251 study?
This clinical trial studies the following conditions: Neoplasms, Carcinoma.
What interventions are being tested in trial NCT04931251?
The interventions under investigation include: Financial Navigation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04931251?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04931251 being conducted?
This trial has 8 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04931251's enrollment target sits among peer trials
258 37th of 158 higher than 122 of 158 other Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endometrial Cell Collection With the PadKit
RECRUITING · NA
-
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
RECRUITING · NA
-
Biennial CEM in Women With a Personal History of Breast Cancer
RECRUITING · NA
-
LITT Followed by Hypofractionated RT for Recurrent Gliomas
RECRUITING · NA
-
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
RECRUITING · NA
-
Screening Strategies Among High-risk Populations for Anal Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03785288 · 258 participants · Phase 3
Vaginal Cuff Brachytherapy Fractionation Study
- NCT04643002 · 258 participants · Phase 1
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
- NCT04924322 · 258 participants · Phase 2
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- NCT05043012 · 258 participants · NA
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI